MoleGear: A Java-Based Platform for Evolutionary De Novo Molecular Design

A Java-based platform, MoleGear, is developed for de novo molecular design based on the chemistry development kit (CDK) and other Java packages. MoleGear uses evolutionary algorithm (EA) to explore chemical space, and a suite of fragment-based operators of growing, crossover, and mutation for assembling novel molecules that can be scored by prediction of binding free energy or a weighted-sum multi-objective fitness function. The EA can be conducted in parallel over multiple nodes to support large-scale molecular optimizations. Some complementary utilities such as fragment library design, chemical space analysis, and graphical user interface are also integrated into MoleGear. The candidate molecules as inhibitors for the human immunodeficiency virus 1 (HIV-1) protease were designed by MoleGear, which validates the potential capability for de novo molecular design.

[1]  Xuezhong He,et al.  MoDoop: An Automated Computational Approach for COSMO-RS Prediction of Biopolymer Solubilities in Ionic Liquids , 2019, ACS omega.

[2]  Hans-Joachim Böhm,et al.  The computer program LUDI: A new method for the de novo design of enzyme inhibitors , 1992, J. Comput. Aided Mol. Des..

[3]  Yoshimasa Takahashi,et al.  De Novo Design of Drug-Like Molecules by a Fragment-Based Molecular Evolutionary Approach , 2014, J. Chem. Inf. Model..

[4]  Wolfgang Guba,et al.  Recent developments in de novo design and scaffold hopping. , 2008, Current opinion in drug discovery & development.

[5]  Alejandro Speck-Planche,et al.  Combining Ensemble Learning with a Fragment-Based Topological Approach To Generate New Molecular Diversity in Drug Discovery: In Silico Design of Hsp90 Inhibitors , 2018, ACS omega.

[6]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[7]  Vidar R. Jensen,et al.  An evolutionary algorithm for de novo optimization of functional transition metal compounds. , 2012, Journal of the American Chemical Society.

[8]  Jie Xia,et al.  Comparative Modeling and Benchmarking Data Sets for Human Histone Deacetylases and Sirtuin Families , 2015, J. Chem. Inf. Model..

[9]  Peter Willett,et al.  The Extent of the Relationship between the Graph-Theoretical and the Geometrical Shape Coefficients of Chemical Compounds , 1995, J. Chem. Inf. Comput. Sci..

[10]  P. Jurs,et al.  Development and use of charged partial surface area structural descriptors in computer-assisted quantitative structure-property relationship studies , 1990 .

[11]  Max W. Chang,et al.  Virtual Screening for HIV Protease Inhibitors: A Comparison of AutoDock 4 and Vina , 2010, PloS one.

[12]  Olexandr Isayev,et al.  Deep reinforcement learning for de novo drug design , 2017, Science Advances.

[13]  Mark S. Johnson,et al.  Generating Conformer Ensembles Using a Multiobjective Genetic Algorithm , 2007, J. Chem. Inf. Model..

[14]  Juliano B. Carregal,et al.  Docking-based virtual screening of Brazilian natural compounds using the OOMT as the pharmacological target database , 2017, Journal of Molecular Modeling.

[15]  Xiangping Zhang,et al.  Computational prediction of cellulose solubilities in ionic liquids based on COSMO-RS , 2018, Fluid Phase Equilibria.

[16]  Zhiliang Li,et al.  Approach to Estimation and Prediction for Normal Boiling Point (NBP) of Alkanes Based on a Novel Molecular Distance-Edge (MDE) Vector , 1998, J. Chem. Inf. Comput. Sci..

[17]  Xiaoqin Zou,et al.  Docking-based inverse virtual screening: methods, applications, and challenges , 2018, Biophysics reports.

[18]  N. R. Shiju,et al.  De novo design of nanostructured iron-cobalt Fischer-Tropsch catalysts. , 2013, Angewandte Chemie.

[19]  Hiromasa Kaneko,et al.  Chemical-Space-Based de Novo Design Method To Generate Drug-Like Molecules , 2016, J. Chem. Inf. Model..

[20]  Thomas Bäck,et al.  The Molecule Evoluator. An Interactive Evolutionary Algorithm for the Design of Drug-Like Molecules , 2006, J. Chem. Inf. Model..

[21]  Gisbert Schneider,et al.  Flux (2): Comparison of Molecular Mutation and Crossover Operators for Ligand-Based de Novo Design , 2007, J. Chem. Inf. Model..

[22]  G. Labesse,et al.  LEA3D: a computer-aided ligand design for structure-based drug design. , 2005, Journal of medicinal chemistry.

[23]  Constantinos S. Pattichis,et al.  De Novo Drug Design Using Multiobjective Evolutionary Graphs , 2009, J. Chem. Inf. Model..

[24]  Gisbert Schneider,et al.  Flux (1): A Virtual Synthesis Scheme for Fragment-Based de Novo Design , 2006, J. Chem. Inf. Model..

[25]  Ge-Fei Hao,et al.  Computational discovery of picomolar Q(o) site inhibitors of cytochrome bc1 complex. , 2012, Journal of the American Chemical Society.

[26]  Paola Gramatica,et al.  New 3D Molecular Descriptors: The WHIM theory and QSAR Applications , 2002 .

[27]  Egon L. Willighagen,et al.  The Blue Obelisk—Interoperability in Chemical Informatics , 2006, J. Chem. Inf. Model..

[28]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[29]  Brian D. Hudson,et al.  Parameter Based Methods for Compound Selection from Chemical Databases , 1996 .

[30]  Egon L. Willighagen,et al.  The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo-and Bioinformatics , 2003, J. Chem. Inf. Comput. Sci..

[31]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[32]  Marialva Sinigaglia,et al.  New Insights into the In Silico Prediction of HIV Protease Resistance to Nelfinavir , 2014, PloS one.

[33]  B. Alsberg,et al.  A knowledge‐based approach for screening chemical structures within de novo molecular evolution , 2010 .

[34]  L. Lai,et al.  Calculating partition coefficient by atom-additive method , 2000 .

[35]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[36]  P. Trojer,et al.  Target-based approach to inhibitors of histone arginine methyltransferases. , 2007, Journal of medicinal chemistry.

[37]  Tarak K Patra,et al.  Neural-Network-Biased Genetic Algorithms for Materials Design: Evolutionary Algorithms That Learn. , 2017, ACS combinatorial science.

[38]  Gisbert Schneider,et al.  Computer-based de novo design of drug-like molecules , 2005, Nature Reviews Drug Discovery.

[39]  S. Holbeck,et al.  Update on NCI in vitro drug screen utilities. , 2004, European journal of cancer.

[40]  Peter C. Jurs,et al.  Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..

[41]  P. Sautet,et al.  In Silico Screening of Iron-Oxo Catalysts for CH Bond Cleavage , 2015 .

[42]  Y. Tseng,et al.  Template-Based de Novo Design for Type II Kinase Inhibitors and Its Extended Application to Acetylcholinesterase Inhibitors , 2013, Molecules.

[43]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[44]  John C. Eslick,et al.  Design of ionic liquids via computational molecular design , 2010, Comput. Chem. Eng..